PEG 3350 Market Research Report Information by Product Type (Powder, Bowel Preparation Kit) by Age (Pediatric, Adult, and Geriatric) by Application (Constipation, Medical Tests, [Colonoscopy and Barium Enema X-Ray Examination], and Surgery) by Distribution Channel (Online Pharmacy, Offline Pharmacy), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING PREVALENCE OF COLON CANCER IN INDIA AND OTHER DEVELOPING NATIONS

4.2.2 RISING NUMBER OF STRATEGIC INITIATIVES

4.2.3 INCREASING SEDENTARY LIFESTYLE AND PHYSICAL INACTIVITY

4.3 RESTRAINTS

4.3.1 SIDE EFFECTS ASSOCIATED WITH PEG 3500

4.3.2 INCREASING PREFERENCE FOR ORGANIC ALTERNATIVES

4.4 OPPORTUNITIES

4.4.1 ENTERING DEVELOPING MARKETS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION

5.1.4 MARKETING & SALES

5.1.5 POST-SALES REVIEW/MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL PEG 3350 MARKET

5.3.1 IMPACT ON DEMAND

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL PEG 3350 MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 POWDER

6.3 BOWEL PREPARATION KIT

7 GLOBAL PEG 3350 MARKET, BY AGE

7.1 OVERVIEW

7.2 PEDIATRIC

7.3 ADULT

7.4 GERIATRIC

8 GLOBAL PEG 3350 MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 CONSTIPATION

8.3 MEDICAL TESTS

8.3.1 COLONOSCOPY

8.3.2 BARIUM ENEMA X-RAY EXAMINATION

8.4 SURGERY

9 GLOBAL PEG 3350 MARKET, BY DISTRIBUTION CHANNEL

9.1 OVERVIEW

9.2 ONLINE PHARMACY

9.3 OFFLINE PHARMACY

10 GLOBAL PEG 3350 MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 UK

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PEG 3350 MARKET

11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PEG 3350 MARKET

11.5 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.5.1 PRODUCT LAUNCH/PRODUCT APPROVAL

12 COMPANY PROFILES

12.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL ANALYSIS

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 KEY STRATEGIES

12.2 LGM PHARMA

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS/SERVICES OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 KEY STRATEGIES

12.3 MCKESSON CORPORATION

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 SISCO RESEARCH LABORATORIES PVT. LTD.

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS/SERVICES OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 KEY STRATEGIES

12.5 BASF SE

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 MERCK KGAA

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 BAYER AG

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 LUPIN PHARMACEUTICALS, INC.

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 BRECKENRIDGE PHARMACEUTICAL, INC.

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

12.10 PENDOPHARM

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 4 GLOBAL PEG 3350 MARKET, FOR POWDER, BY REGION, 2019–2032 (USD BILLION)

TABLE 5 GLOBAL PEG 3350 MARKET, FOR BOWEL PREPARATION KIT, BY REGION, 2019–2032 (USD BILLION)

TABLE 6 GLOBAL PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 7 GLOBAL PEG 3350 MARKET, FOR PEDIATRIC, BY REGION, 2019–2032 (USD BILLION)

TABLE 8 GLOBAL PEG 3350 MARKET, FOR ADULT, BY REGION, 2019–2032 (USD BILLION)

TABLE 9 GLOBAL PEG 3350 MARKET, FOR GERIATRIC, BY REGION, 2019–2032 (USD BILLION)

TABLE 10 GLOBAL PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 11 GLOBAL PEG 3350 MARKET, FOR CONSTIPATION, BY REGION, 2019–2032 (USD BILLION)

TABLE 12 GLOBAL PEG 3350 MARKET, FOR MEDICAL TESTS, BY REGION, 2019–2032 (USD BILLION)

TABLE 13 GLOBAL PEG 3350 MARKET, FOR COLONOSCOPY, BY REGION, 2019–2032 (USD BILLION)

TABLE 14 GLOBAL PEG 3350 MARKET, FOR BARIUM ENEMA X-RAY EXAMINATION, BY REGION, 2019–2032 (USD BILLION)

TABLE 15 GLOBAL PEG 3350 MARKET, FOR SURGERY, BY REGION, 2019–2032 (USD BILLION)

TABLE 16 GLOBAL PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 17 GLOBAL PEG 3350 MARKET, FOR ONLINE PHARMACY, BY REGION, 2019–2032 (USD BILLION)

TABLE 18 GLOBAL PEG 3350 MARKET, FOR OFFLINE PHARMACY, BY REGION, 2019–2032 (USD BILLION)

TABLE 19 GLOBAL: PEG 3350 MARKET, BY REGION, 2019–2032 (USD BILLION)

TABLE 20 NORTH AMERICA: PEG 3350 MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 21 NORTH AMERICA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 22 NORTH AMERICA: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 23 NORTH AMERICA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 24 NORTH AMERICA: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)

TABLE 25 NORTH AMERICA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 26 US: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 27 US: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 28 US: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 29 US: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)

TABLE 30 US: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 31 CANADA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 32 CANADA: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 33 CANADA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 34 CANADA: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)

TABLE 35 CANADA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 36 EUROPE: PEG 3350 MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 37 EUROPE: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 38 EUROPE: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 39 EUROPE: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 40 EUROPE: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 41 EUROPE: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 42 GERMANY: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 43 GERMANY: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 44 GERMANY: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 45 GERMANY: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 46 GERMANY: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 47 FRANCE: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 48 FRANCE: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 49 FRANCE: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 50 FRANCE: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 51 FRANCE: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 52 UK: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 53 UK: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 54 UK: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 55 UK: PEG 3350 MARKET, FOR MEDICAL TESTS BY TYPE, 2019–2032 (USD BILLION)

TABLE 56 UK: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 57 ITALY: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 58 ITALY: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 59 ITALY: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 60 ITALY: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 61 ITALY: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 62 SPAIN: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 63 SPAIN: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 64 SPAIN: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 65 SPAIN: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 66 SPAIN: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 67 REST OF EUROPE: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 68 REST OF EUROPE: PEG 3350 MARKET, BY AGE, 2019–2032 (USD BILLION)

TABLE 69 REST OF EUROPE: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 70 REST OF EUROPE: PEG 3350 MARKET, FOR MEDICAL TESTS, BY TYPE, 2019–2032 (USD BILLION)

TABLE 71 REST OF EUROPE: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 72 ASIA-PACIFIC: PEG 3350 MARKET, BY COUNTRY, 2019–2032 (USD BILLION)

TABLE 73 ASIA-PACIFIC: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 74 ASIA-PACIFIC: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 75 ASIA-PACIFIC: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 76 ASIA-PACIFIC: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 77 ASIA-PACIFIC: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 78 CHINA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 79 CHINA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 80 CHINA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 81 CHINA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 82 CHINA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 83 INDIA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 84 INDIA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 85 INDIA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 86 INDIA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 87 INDIA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 88 JAPAN: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 89 JAPAN: PEG 3350 MARKET, BY AGE, 2018-2030(USD BILLION) (USD BILLION)

TABLE 90 JAPAN: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 91 JAPAN: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 92 JAPAN: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 93 SOUTH KOREA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 94 SOUTH KOREA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 95 SOUTH KOREA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 96 SOUTH KOREA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 97 SOUTH KOREA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 98 AUSTRALIA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 99 AUSTRALIA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 100 AUSTRALIA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 101 AUSTRALIA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 102 AUSTRALIA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 103 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 104 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 105 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 106 REST OF ASIA PACIFIC: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 107 REST OF ASIA PACIFIC: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 108 REST OF THE WORLD: PEG 3350 MARKET, BY COUNTRY, 2018-2030 (USD BILLION)

TABLE 109 REST OF THE WORLD: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 110 REST OF THE WORLD: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 111 REST OF THE WORLD: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 112 REST OF THE WORLD: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 113 REST OF THE WORLD: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 114 MIDDLE EAST: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 115 MIDDLE EAST: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 116 MIDDLE EAST: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 117 MIDDLE EAST: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 118 MIDDLE EAST: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 119 AFRICA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 120 AFRICA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 121 AFRICA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 122 AFRICA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 123 AFRICA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 124 LATIN AMERICA: PEG 3350 MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)

TABLE 125 LATIN AMERICA: PEG 3350 MARKET, BY AGE, 2018-2030 (USD BILLION)

TABLE 126 LATIN AMERICA: PEG 3350 MARKET, BY APPLICATION, 2019–2032 (USD BILLION)

TABLE 127 LATIN AMERICA: PEG 3350 MARKET FOR MEDICAL TEST, BY TYPE, 2019–2032 (USD BILLION)

TABLE 128 LATIN AMERICA: PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2019–2032 (USD BILLION)

TABLE 129 MAJOR PLAYERS IN THE GLOBAL PEG 3350 MARKET

TABLE 130 MOST ACTIVE PLAYER IN THE GLOBAL PEG 3350 MARKET

TABLE 131 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 132 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS/SERVICES OFFERED

TABLE 133 LGM PHARMA: PRODUCTS/SERVICES OFFERED

TABLE 134 MCKESSON CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 135 SISCO RESEARCH LABORATORIES PVT. LTD.: PRODUCTS/SERVICES OFFERED

TABLE 136 BASF SE: PRODUCTS/SERVICES OFFERED

TABLE 137 MERCK KGAA: PRODUCTS OFFERED

TABLE 138 BAYER AG: PRODUCTS OFFERED

TABLE 139 BAYER AG: KEY DEVELOPMENTS

TABLE 140 LUPIN PHARMACEUTICALS, INC.: PRODUCTS OFFERED

TABLE 141 BRECKENRIDGE PHARMACEUTICAL, INC.: PRODUCTS OFFERED

TABLE 142 PENDOPHARM: PRODUCTS OFFERED

TABLE 143 PENDOPHARM: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL PEG 3350 MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PEG 3350 MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL PEG 3350 MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PEG 3350 MARKET

FIGURE 9 GLOBAL PEG 3350 MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD BILLION)

FIGURE 10 GLOBAL PEG 3350 MARKET, BY AGE, 2022 & 2032 (USD BILLION)

FIGURE 11 GLOBAL PEG 3350 MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)

FIGURE 12 GLOBAL PEG 3350 MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2032 (USD BILLION)

FIGURE 13 GLOBAL: PEG 3350 MARKET, BY REGION 2022 & 2032 (USD BILLION)

FIGURE 14 GLOBAL: PEG 3350 MARKET SHARE (%), BY REGION, 2022

FIGURE 15 NORTH AMERICA: PEG 3350 MARKET SHARE (%), BY COUNTRY 2022

FIGURE 16 EUROPE: PEG 3350 MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 17 ASIA-PACIFIC: PEG 3350 MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 18 REST OF THE WORLD: PEG 3350 MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PEG 3350 MARKET

FIGURE 21 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 MCKESSON CORPORATION: SWOT ANALYSIS

FIGURE 24 BASF SE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 BASF SE: SWOT ANALYSIS

FIGURE 26 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 MERCK KGAA: SWOT ANALYSIS

FIGURE 28 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 BAYER AG: SWOT ANALYSIS

FIGURE 30 LUPIN PHARMACEUTICALS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 LUPIN PHARMACEUTICALS, INC.: SWOT ANALYSIS